Evidence map›Paper›PMID 31497045›Full record

ArticlePostepy w kardiologii interwencyjnej = Advances in interventional cardiology2019

Zero-contrast percutaneous coronary interventions to preserve kidney function in patients with severe renal impairment and hemodialysis subjects.

Jerzy Sacha, Marek Gierlotka, Przemysław Lipski, Piotr Feusette, Dariusz Dudek

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. How to perform ostial stenting without contrast administration.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2020
    Article
  14. Review
  15. Observational
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Jerzy SachaDepartment of Cardiology, University Hospital, Faculty of Natural Sciences and Technology, University of Opole, Opole, Poland.
Marek GierlotkaDepartment of Cardiology, University Hospital, Faculty of Natural Sciences and Technology, University of Opole, Opole, Poland.
Przemysław LipskiDepartment of Cardiology, University Hospital, Faculty of Natural Sciences and Technology, University of Opole, Opole, Poland.
Piotr FeusetteDepartment of Cardiology, University Hospital, Faculty of Natural Sciences and Technology, University of Opole, Opole, Poland.
Dariusz DudekInstitute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
University of Opole · PLInstitute of Cardiology · PLOpole University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionZero-contrast percutaneous coronary intervention (zero-PCI) is a new method for prevention of contrast-induced acute kidney injury (AKI) in patients with chronic kidney disease (CKD). However, evidence for its feasibility, safety and clinical utility is limited to reports of single cases or series of patients.

aimTo present outcomes of zero-PCI in patients with severe CKD, including hemodialysis subjects, who were treated with this procedure in order to preserve their renal function. MATERIAL AND

methodsTwenty-nine zero-PCIs were performed, mostly as a staged procedure, in 20 patients with advanced CKD. In this group, 4 patients were treated with hemodialysis but presented preserved residual renal function. The estimated median risk for contrast-induced AKI in non-dialysis patients was 26% (26-57%).

resultsZero-PCI was feasible in each intended patient, including those with complex left main stenosis or lesion within a saphenous vein graft, and there was no specific complication associated with this technique. After the procedure, the factual AKI prevalence was 10% and no patient required renal replacement therapy. Three of 4 hemodialysis patients preserved their residual renal function. During the median follow-up of 3.2 (1.2-5.3) months no patient experienced an acute coronary event or required revascularization.

conclusionsZero-PCI is a safe and promising method to preserve renal function in patients with CKD and hemodialysis patients. Such an approach is feasible even in complex coronary lesions and yields good clinical outcomes in mid-term observation.

Indexed as

acute kidney injurycontrast-induced nephropathyrenal insufficiencyzero-contrast percutaneous coronary intervention

Identifiers

PMID31497045
PMCPMC6727221
OpenAlexW2954059580

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.